The growth in the ECG Market can primarily be attributed to factors such as the increasing incidence of cardiovascular diseases and technological advancements in devices.
According to research report the global ECG market size $8.1 billion in 2023 and is poised to reach $11.3 billion by 2028, growing at a CAGR of 6.9% from 2023 to 2028.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173
Diagnostic ECG devices segment is expected to account for the largest share in 2022.
Based on product type, the diagnostic ECG market is segmented into devices and software and services. The devices segment accounted for the largest share of diagnostic ECG market in 2022 owing to the increasing application of diagnostic ECG devices in the management of cardiovascular disease and growing presence of wide range of cost-effective ECG devices in the market
The 12-lead segment held the largest market share in the Diagnostic Electrocardiogram (ECG) market.
Based on lead type, the diagnostic electrocardiogram (ECG) market is segmented into patch type 12-lead, 5-lead, 3-lead, 6-lead, single lead, and other lead types (such as 13 lead, 18- lead). In 2022, the 12-lead segment accounted for the largest share of the diagnostic ECG attributed to clarity obtained by using 12 lead providing detailed outlook, making the interpretation of cardiac activity easier.
The hospitals, clinics, and Cardiac Centers segment dominated the Diagnostic Electrocardiogram (ECG) market in 2022.
Based on end user, the diagnostic electrocardiogram (ECG) market is segmented into hospitals, clinics, and Cardiac Centers, ambulatory surgical centers, and other end users. The hospitals, clinics, and Cardiac Centers segment accounted for the largest share of the global market in 2022 attributed to the growing incidence of cardiovascular diseases, rising number of hospitals & cardiac centers, and increase in the patient visits to physician offices for the diagnosis of CVDs.
North America dominates the global Diagnostic Electrocardiogram (ECG) market
Based on the region segmentation, the Diagnostic Electrocardiogram (ECG) market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East Africa. North America holds the largest share and expects to dominate the Diagnostic Electrocardiogram (ECG) market. The large share of the North American market can be attributed to the increasing healthcare spending, rising incidence of CVD, and rapid adoption of technologically advanced ECG devices in the region.
The major players in the global diagnostic ECG market are Koninklijke Philips (Netherlands), GE Healthcare (US), and Nihon Kohden Corporation (Japan). These players have adopted various growth strategies such as service product launches, partnerships collaborations, and mergers expansions to increase their presence in the global market.
Koninklijke Philips (Netherlands) was one of the major players operating in the diagnostic ECG market in 2018. The company’s major products include the Stress ECG testing system, ECG software management system, Holter monitors, and cardiographs. Philips Group operates in the Asia Pacific, Europe, North America, and Africa. In 2016, Philips Healthcare collaborated with the Rostock University Medical Center (Germany) to deliver networked cardiac care across Germany.
GE Healthcare (US) is among the leading players in the diagnostic ECG market. The company provides a range of diagnostic ECG products, including resting, stress, and ambulatory ECGs, as well as ECG software. The company focuses on investing in product RD and clinical studies. The company operates in more than 140 countries across the Americas, Europe, Asia, and the Middle East Africa.
Request Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=173
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
